Search research articles
Contact Us
Filters
Showing results (161-170 of 225) with videos related to
Page
of 23
Sort By:
The New England Journal of Medicine
|
July 18, 2020
Dexamethasone in Hospitalized Patients with Covid-19
, Peter Horby, Wei Shen Lim, et al.
Expert Review of Respiratory Medicine
|
May 14, 2016
Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches
Helena Lund-Palau, Andrew R Turnbull, Andrew Bush, et al.
JAMA Network Open
|
October 12, 2021
Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial
Timo Vesikari, Adam Finn, Pierre van Damme, et al.
Frontiers in Medicine
|
February 26, 2025
Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process
Breanne Stewart, Pirkko Lepola, Gunter F Egger, et al.
The Journal of Infection
|
June 19, 2022
Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults
Rajeka Lazarus, Christian Taucher, Claire Brown, et al.
Health Technology Assessment (Winchester, England)
|
September 2, 2017
Duration of intravenous antibiotic therapy for children with acute osteomyelitis or septic arthritis: a feasibility study
Hans de Graaf, Priya Sukhtankar, Barbara Arch, et al.
JAMA
|
August 24, 2016
Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile Children
Jethro A Herberg, Myrsini Kaforou, Victoria J Wright, et al.
Vaccine
|
August 31, 2011
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines
Nick J Andrews, Woolf T Walker, Adam Finn, et al.
Frontiers in Medicine
|
April 30, 2025
Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process
Breanne Stewart, Pirkko Lepola, Gunter F Egger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 29, 2017
Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis
Robert P Howlin, Katrina Cathie, Luanne Hall-Stoodley, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 225) with videos related to
Sort By:
Page
of 23
The New England Journal of Medicine
|
July 18, 2020
Dexamethasone in Hospitalized Patients with Covid-19
, Peter Horby, Wei Shen Lim, et al.
Expert Review of Respiratory Medicine
|
May 14, 2016
Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches
Helena Lund-Palau, Andrew R Turnbull, Andrew Bush, et al.
JAMA Network Open
|
October 12, 2021
Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial
Timo Vesikari, Adam Finn, Pierre van Damme, et al.
Frontiers in Medicine
|
February 26, 2025
Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process
Breanne Stewart, Pirkko Lepola, Gunter F Egger, et al.
The Journal of Infection
|
June 19, 2022
Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults
Rajeka Lazarus, Christian Taucher, Claire Brown, et al.
Health Technology Assessment (Winchester, England)
|
September 2, 2017
Duration of intravenous antibiotic therapy for children with acute osteomyelitis or septic arthritis: a feasibility study
Hans de Graaf, Priya Sukhtankar, Barbara Arch, et al.
JAMA
|
August 24, 2016
Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile Children
Jethro A Herberg, Myrsini Kaforou, Victoria J Wright, et al.
Vaccine
|
August 31, 2011
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines
Nick J Andrews, Woolf T Walker, Adam Finn, et al.
Frontiers in Medicine
|
April 30, 2025
Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process
Breanne Stewart, Pirkko Lepola, Gunter F Egger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 29, 2017
Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis
Robert P Howlin, Katrina Cathie, Luanne Hall-Stoodley, et al.
Page
of 23